Alligator Bioscience AB - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWIRE) -- 10/09/2012 -- Alligator Bioscience AB - Product Pipeline Review - 2012 provides data on the Alligator Bioscience AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Alligator Bioscience AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Alligator Bioscience AB and industry-specific third party sources, put together by Global Markets Direct’s team.


- Alligator Bioscience AB - Brief Alligator Bioscience AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Alligator Bioscience AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Alligator Bioscience AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Alligator Bioscience AB’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Alligator Bioscience AB’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Alligator Bioscience AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Alligator Bioscience AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Alligator Bioscience AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Alligator Bioscience AB and identify potential opportunities in those areas.


Current R&D Portfolio of Alligator Bioscience AB; Alligator Bioscience AB - Key Therapeutics; Alligator Bioscience AB - Pipeline Overview and Promising Molecules; Alligator Bioscience AB - News; Alligator Bioscience AB - Latest Updates; Alligator Bioscience AB - Pipeline; Alligator Bioscience AB - Discontinued/Dormant Projects

To view table of contents for this market report please visit: